Radcliffe demonstrates how to find the right angle of implantation for Durysta (bimatoprost intracameral implant, Allergan) in order to avoid endothelial cell loss. “I inject a lot of ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension. According to GlobalData, Phase III drugs for Ocular Hypertension have a 75% phase ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...

What just happened? Netflix is suing Broadcom, alleging infringement of multiple patents related to virtual machine operations. The video streaming giant alleges that VMware products like vSphere ...

Video streaming giant Netflix Inc. is suing Broadcom Inc. over virtual machine patents owned by the company’s subsidiary VMware Inc. According to the lawsuit filed with a California federal ...

Netflix claims Broadcom's subsidiary VMware is in violation of five patents It claims VMware knew it was violating patents for more than a decade Netflix is now demanding VMware pays for damages ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

An authorized generic is different from a generic drug, according to the FDA, because it’s the “exact same drug product” as a branded drug, just without the brand name on the label.

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens new tab said on Monday they have reached an agreement to settle all patent disputes between them related to ...